Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cortical lesions in multiple sclerosis: inflammation versus neurodegeneration.
Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.
Multiple sclerosis: Preventing progression and disability in MS-when to treat?
Neural drive increases following resistance training in patients with multiple sclerosis.
Multiple Sclerosis and HERV-W/MSRV: A Multicentric Study.
Neurofascin 186 specific autoantibodies induce axonal injury and exacerbate disease severity in experimental autoimmune encephalomyelitis.
Erythropoietin (EPO) increases myelin gene expression in CG4 oligodendrocyte cells through the classical EPO receptor.
1H-Magnetic Resonance Spectroscopy in diffuse and focal cervical cord lesions in Multiple Sclerosis.
Immunoablation of cells expressing the NG2 chondroitin sulphate proteoglycan.
Sphingosine-1-phosphate Receptor 1 (S1P1 ) Signaling in T cells: Trafficking and Beyond.
IgM-monoclonal gammopathy neuropathy and tremor: A first epidemiologic case control study.
Emerging stem cell therapies: treatment, safety, and biology.
Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies.
Modeling the course and outcomes of multiple sclerosis is statistical twaddle-Yes.
Low Prevalence of Sleep Disorders in Demyelinating Disease in a Northern Tenerife Population.
Supernumerary phantom limbs in ICU patients with acute inflammatory demyelinating polyneuropathy.
Recurrent paraparesis and death of a patient with 'whippet' abuse.
Google Trends: new evidence for seasonality of multiple sclerosis.
Mechanisms of restriction of viral neuroinvasion at the blood-brain barrier.
Reduced perfusion in white matter lesions in multiple sclerosis.
Acute optic neuritis in multiple sclerosis.
European multiple sclerosis risk variants in the south Asian population.
Myelinating Cultures: An In Vitro Tool to Identify Demyelinating and Axopathic Autoantibodies.
Generating induced pluripotent stem cells for multiple sclerosis therapy.
Multiple sclerosis in the far north - incidence and prevalence in Nordland County, Norway, 1970¿2010.

Pages